Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Short

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
British Journal of Clinical Pharmacology|October 1, 1988
Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphyS S Davis, N Washington, G D Parr, et al.
Neurology|November 1, 1989
Gastrointestinal transit of Sinemet CR in healthy volunteersI R Wilding, S S Davis, C D Melia, et al.
British Journal of Clinical Pharmacology|November 1, 1978
Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]A T Birmingham, A J Coleman, M L Orme, et al.
Clinical Neuropharmacology|August 1, 1991
Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR)I R Wilding, J G Hardy, S S Davis, et al.
British Journal of Pharmacology|November 1, 1979
Student-constructed hydraulic and mechanical models for learning fundamentals of pharmacokinetics [proceedings]J R Bradley, R J Fayle, N J Harmsworth, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
British Journal of Clinical Pharmacology|October 1, 1988
Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphyS S Davis, N Washington, G D Parr, et al.
Neurology|November 1, 1989
Gastrointestinal transit of Sinemet CR in healthy volunteersI R Wilding, S S Davis, C D Melia, et al.
British Journal of Clinical Pharmacology|November 1, 1978
Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]A T Birmingham, A J Coleman, M L Orme, et al.
Clinical Neuropharmacology|August 1, 1991
Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR)I R Wilding, J G Hardy, S S Davis, et al.
British Journal of Pharmacology|November 1, 1979
Student-constructed hydraulic and mechanical models for learning fundamentals of pharmacokinetics [proceedings]J R Bradley, R J Fayle, N J Harmsworth, et al.
Pageof 4